KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer
Abstract There are limited data on circulating, cell-free, tumour (ct)DNA analysis in locally advanced rectal cancer (LARC). Digital droplet (dd)PCR was used to investigate KRAS/BRAF mutations in ctDNA from baseline blood samples of 97 LARC patients who were treated with CAPOX followed by chemoradio...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2018
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/2003b11877bd4935942baabe372bee21 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:2003b11877bd4935942baabe372bee21 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:2003b11877bd4935942baabe372bee212021-12-02T15:07:50ZKRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer10.1038/s41598-018-19212-52045-2322https://doaj.org/article/2003b11877bd4935942baabe372bee212018-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-19212-5https://doaj.org/toc/2045-2322Abstract There are limited data on circulating, cell-free, tumour (ct)DNA analysis in locally advanced rectal cancer (LARC). Digital droplet (dd)PCR was used to investigate KRAS/BRAF mutations in ctDNA from baseline blood samples of 97 LARC patients who were treated with CAPOX followed by chemoradiotherapy, surgery and adjuvant CAPOX ± cetuximab in a randomised phase II trial. KRAS mutation in G12D, G12V or G13D was detected in the ctDNA of 43% and 35% of patients with tumours that were mutant and wild-type for these hotspot mutations, respectively, according to standard PCR-based analyses on tissue. The detection rate in the ctDNA of 10 patients with less common mutations was 50%. In 26 cases ctDNA analysis revealed KRAS mutations that were not previously found in tissue. Twenty-two of these (84.6%) were detected following repeat tissue testing by ddPCR. Overall, the ctDNA detection rate in the KRAS mutant population was 66%. Detection of KRAS mutation in ctDNA failed to predict prognosis or refine patient selection for cetuximab. While this study confirms the feasibility of ctDNA analysis in LARC and the high sensitivity of ddPCR, larger series are needed to better address the role of ctDNA as a prognostic or predictive tool in this setting.Francesco SclafaniIan ChauDavid CunninghamJens C. HahneGeorge VlachogiannisZakaria EltahirAndrea LampisChiara BraconiEleftheria KalaitzakiDavid Gonzalez De CastroAndrew WotherspoonJaume CapdevilaBengt GlimeliusNoelia TarazonaRuwaida BegumHazel LoteSanna Hulkki WilsonGiulia MentrastiGina BrownDiana TaitJacqueline OatesNicola ValeriNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-9 (2018) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Francesco Sclafani Ian Chau David Cunningham Jens C. Hahne George Vlachogiannis Zakaria Eltahir Andrea Lampis Chiara Braconi Eleftheria Kalaitzaki David Gonzalez De Castro Andrew Wotherspoon Jaume Capdevila Bengt Glimelius Noelia Tarazona Ruwaida Begum Hazel Lote Sanna Hulkki Wilson Giulia Mentrasti Gina Brown Diana Tait Jacqueline Oates Nicola Valeri KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer |
| description |
Abstract There are limited data on circulating, cell-free, tumour (ct)DNA analysis in locally advanced rectal cancer (LARC). Digital droplet (dd)PCR was used to investigate KRAS/BRAF mutations in ctDNA from baseline blood samples of 97 LARC patients who were treated with CAPOX followed by chemoradiotherapy, surgery and adjuvant CAPOX ± cetuximab in a randomised phase II trial. KRAS mutation in G12D, G12V or G13D was detected in the ctDNA of 43% and 35% of patients with tumours that were mutant and wild-type for these hotspot mutations, respectively, according to standard PCR-based analyses on tissue. The detection rate in the ctDNA of 10 patients with less common mutations was 50%. In 26 cases ctDNA analysis revealed KRAS mutations that were not previously found in tissue. Twenty-two of these (84.6%) were detected following repeat tissue testing by ddPCR. Overall, the ctDNA detection rate in the KRAS mutant population was 66%. Detection of KRAS mutation in ctDNA failed to predict prognosis or refine patient selection for cetuximab. While this study confirms the feasibility of ctDNA analysis in LARC and the high sensitivity of ddPCR, larger series are needed to better address the role of ctDNA as a prognostic or predictive tool in this setting. |
| format |
article |
| author |
Francesco Sclafani Ian Chau David Cunningham Jens C. Hahne George Vlachogiannis Zakaria Eltahir Andrea Lampis Chiara Braconi Eleftheria Kalaitzaki David Gonzalez De Castro Andrew Wotherspoon Jaume Capdevila Bengt Glimelius Noelia Tarazona Ruwaida Begum Hazel Lote Sanna Hulkki Wilson Giulia Mentrasti Gina Brown Diana Tait Jacqueline Oates Nicola Valeri |
| author_facet |
Francesco Sclafani Ian Chau David Cunningham Jens C. Hahne George Vlachogiannis Zakaria Eltahir Andrea Lampis Chiara Braconi Eleftheria Kalaitzaki David Gonzalez De Castro Andrew Wotherspoon Jaume Capdevila Bengt Glimelius Noelia Tarazona Ruwaida Begum Hazel Lote Sanna Hulkki Wilson Giulia Mentrasti Gina Brown Diana Tait Jacqueline Oates Nicola Valeri |
| author_sort |
Francesco Sclafani |
| title |
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer |
| title_short |
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer |
| title_full |
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer |
| title_fullStr |
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer |
| title_full_unstemmed |
KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer |
| title_sort |
kras and braf mutations in circulating tumour dna from locally advanced rectal cancer |
| publisher |
Nature Portfolio |
| publishDate |
2018 |
| url |
https://doaj.org/article/2003b11877bd4935942baabe372bee21 |
| work_keys_str_mv |
AT francescosclafani krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT ianchau krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT davidcunningham krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT jenschahne krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT georgevlachogiannis krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT zakariaeltahir krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT andrealampis krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT chiarabraconi krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT eleftheriakalaitzaki krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT davidgonzalezdecastro krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT andrewwotherspoon krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT jaumecapdevila krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT bengtglimelius krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT noeliatarazona krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT ruwaidabegum krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT hazellote krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT sannahulkkiwilson krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT giuliamentrasti krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT ginabrown krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT dianatait krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT jacquelineoates krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer AT nicolavaleri krasandbrafmutationsincirculatingtumourdnafromlocallyadvancedrectalcancer |
| _version_ |
1718388371237109760 |